SIP 1.55% $1.31 sigma pharmaceuticals limited

UBS downgraded SIP, page-4

  1. 8,839 Posts.
    lightbulb Created with Sketch. 1048
    Really good point, and I fully agree that a lot of analysts are reactive not proactive. I will be very interested in the next announcement , not so much the figures but guidance and what they are doing in the hospital supply chain. Imo this area is a great opportunity for SIP growth and particularly an area for increase in EBIT.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.